SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019140
Filing Date
2023-05-09
Accepted
2023-05-09 07:31:10
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tngx-20230331.htm   iXBRL 10-Q 1972216
2 EX-31.1 tngx-ex31_1.htm EX-31 19806
3 EX-31.2 tngx-ex31_2.htm EX-31 19728
4 EX-32.1 tngx-ex32_1.htm EX-32 9587
5 EX-32.2 tngx-ex32_2.htm EX-32 9578
  Complete submission text file 0000950170-23-019140.txt   7174598

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tngx-20230331_def.xml EX-101.DEF 155190
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tngx-20230331_lab.xml EX-101.LAB 340086
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tngx-20230331_pre.xml EX-101.PRE 237277
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tngx-20230331.xsd EX-101.SCH 36411
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tngx-20230331_cal.xml EX-101.CAL 42267
53 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20230331_htm.xml XML 1460816
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 23899989
SIC: 2834 Pharmaceutical Preparations